LGALS3 and neoplasm: In the tumor microenvironment, the extracellular galectin-3 interacted with effector molecule, interferon (IFN)-γ, owing to its extensive glycosylation and dampened its protective function against the developing tumor (Gordon-Alonso et al., 2017).